Literature DB >> 7672623

Protective role of excitatory amino acid antagonists in experimental retinal ischemia.

M Weber1, N Bonaventure, J A Sahel.   

Abstract

BACKGROUND: Excitatory amino acids and their analogues (NMDA, kainate and AMPA) are implicated in the pathogenesis of ischemic brain injury. In order to fully understand their involvement in the pathogenesis of retinal ischemic injury, we studied the electrophysiological and histopathological effects of two excitatory amino acid antagonists, cis-PDA and MK 801, in an experimental retinal ischemia model.
METHODS: The two antagonists were injected intravitreously 15 min before ischemia was induced by elevatory intraocular pressure caused by external compression. Electrophysiological and histopathological evaluation was made 48 h after 45 min transient ischemia.
RESULTS: The excitatory amino acid antagonists cis-PDA and MK 801 can partially protect against retinal ischemic injury; whereas the mean post-ischemic b-wave amplitude corresponded to 41% of the pre-ischemic value in the control group, it was 64% (P = 0.003) and 59% (P = 0.005) following administration of cis-PDA and MK 801 respectively. Histopathological study corroborated these data, showing significant differences for morphometric parameters (P = 0.011 and P = 0.007 respectively).
CONCLUSION: These preliminary results suggest the possibility of limiting excito-toxicity, one of the lesion-forming mechanisms in ischemic retinal injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672623     DOI: 10.1007/bf00200485

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

Review 1.  Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists.

Authors:  J C Watkins; P Krogsgaard-Larsen; T Honoré
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

Review 2.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

Review 3.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

4.  Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro.

Authors:  J Drejer; H Benveniste; N H Diemer; A Schousboe
Journal:  J Neurochem       Date:  1985-07       Impact factor: 5.372

5.  Effects of anoxia on the stimulated release of amino acid neurotransmitters in the cerebellum in vitro.

Authors:  T M Bosley; P L Woodhams; R D Gordon; R Balázs
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

6.  Amino acid neurotoxicity: relationship to neuronal depolarization in rat cerebellar slices.

Authors:  J Garthwaite; G Garthwaite; F Hajós
Journal:  Neuroscience       Date:  1986-06       Impact factor: 3.590

7.  MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate.

Authors:  A M el-Asrar; P H Morse; D Maimone; E Torczynski; A T Reder
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

8.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Authors:  R P Simon; J H Swan; T Griffiths; B S Meldrum
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

9.  The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat.

Authors:  G W Bielenberg; T Beck
Journal:  Brain Res       Date:  1991-06-28       Impact factor: 3.252

10.  MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain.

Authors:  J W Olney; C Ikonomidou; J L Mosinger; G Frierdich
Journal:  J Neurosci       Date:  1989-05       Impact factor: 6.167

View more
  7 in total

1.  Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells.

Authors:  Shinichiro Saito; Masaaki Ohashi; Akira Naito; Yasuhiro Fukaya; Yasuyuki Suzuki; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Adenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats.

Authors:  T Konno; A Sato; T Uchibori; A Nagai; K Kogi; N Nakahata
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

3.  Calcium antagonists in N-methyl d-aspartate-induced retinal injury.

Authors:  Murat Kaya; Murat Tunç; Talha Ozdemir; Irfan Altuntaş
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

4.  Neurodegeneration in diabetic retina and its potential drug targets.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

5.  Neurodegeneration and neuroprotection in diabetic retinopathy.

Authors:  Mohammad Shamsul Ola; Mohd Imtiaz Nawaz; Haseeb A Khan; Abdullah S Alhomida
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

Review 6.  Novel drugs and their targets in the potential treatment of diabetic retinopathy.

Authors:  Mohd Imtiaz Nawaz; Marwan Abouammoh; Haseeb A Khan; Abdullah S Alhomida; Mubarak F Alfaran; Mohammad Shamsul Ola
Journal:  Med Sci Monit       Date:  2013-04-26

7.  Neurodegenerative diseases of the retina and potential for protection and recovery.

Authors:  K-G Schmidt; H Bergert; R H W Funk
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.